Emergent BioSolutions CDMO
400 Professional Drive, Suite 400
Gaithersburg, MD 20879
T: +1 800 441 4225 (in the US)
T: +1 240 631 3200 (outside the US)
E: cdmo@ebsi.com
W: https://emergentCDMO.com
LinkedIn: https://www.linkedin.com/showcase/emergent-biosolutions-cdmo


Perfecting Your Formula

Emergent CDMO is dedicated to helping pharma and biotech innovators bring life-saving, life-extending therapies to patients throughout the world. Our development and manufacturing facilities in North America and Europe can support preclinical to commercial production of therapeutics and vaccines. Whether you’re looking for initial process development support, small volumes of material for clinical trials, or large-scale production for a global commercial therapy, our experienced CDMO team is ready to serve as your trusted guide from molecule to market.

Making Your Impossible

Emergent BioSolutions’ mission is to protect and enhance life through innovation. Over the last few decades, Emergent has developed, manufactured, and delivered therapeutics and vaccines throughout the world to tackle the most serious health threats.

Emergent’s CDMO business draws on this experience and has supported the development and manufacture of over 40 commercial and more than 200 clinical programs for their clients. As a dedicated and experienced CDMO solutions partner, clients can leverage Emergent CDMO’s diverse technology platforms, customizable solutions, infrastructure, and capabilities to support the clinical and commercial successes of their molecules.

Technologies & Platforms for Every Strategy

Our CDMO teams have extensive experience and expertise to support biopharma innovators’ needs for a wide range of platforms and technologies including mammalian, microbial, viral, plasma protein-based biotherapeutics and vaccines. Additionally, we can provide process and viral vector development services for gene therapies.

Development Services
-Process Development
-Analytical Development
-Formulation Development
-Lyophilization Development
-Non-GMP Lab-Scale Manufacturing

Drug Substance Manufacturing
-Upstream & Downstream Processing
-Single-Use Platforms (up to 4000L)

Drug Product Manufacturing
-Vials and Prefilled Syringes
-Lyophilization Services
-High Containment Filling (viral and non-viral)
-Packaging & Labeling

Wherever you are in your journey, whatever challenges you face, our team of experts and resources are ready to go to work for you.

Let’s get started with your next clinical or commercial candidate. Your new formula for success awaits.

Recent Webinars

Enhancing our Capabilities for Aseptic Fill/Finish Processing: Introducing the Groninger FlexPro 50

Bridging the Gap Between R&D and Manufacturing

Manufacturing Next-Gen Therapies: The Vanrx SA25 Aseptic Filling Workcell

White Papers

Utilizing Expertise & Experience for Successful Downstream Processing

Benefits of RABS and Isolator Technology in a Changing Regulatory Landscape

Lyophilized Products Are on the Rise: Here’s What You Need to Know